Document is current
Any future updates will be listed below
-
Authors
Conradis-Jansen, Franca
Tripura, Rupam
Peto, Thomas J.
Callery, James J.
Adhikari, Bipin
Ean, Mom
Jongdeepaisal, Monnaphat
Pell, Christopher
Khonputsa, Panarasri
Murgia, Riccardo
Sovannaroth, Siv
Müller, Olaf
Cheah, Phaik Yeong
Dondorp, Arjen M.
von Seidlein, Lorenz
Maude, Richard J.
-
Funding
Funding for this research was provided by:
Global Fund to Fight AIDS, Tuberculosis and Malaria (20864-003-44)
Wellcome (220211)
- License Information
-
More Information
Article History
Received: 28 January 2023
Accepted: 26 May 2023
First Online: 8 June 2023
Declarations
:
: The trial was approved by the Cambodian National Ethics Committee on Health Research (NECHR) reference: 008, 10th January 2020, and Oxford Tropical Research Ethics Committee (OxTREC) approval reference: 534-19, 22nd August 2019. The PAL trial was registered clinicaltrials.gov: NCT04041973 on the 1st of August 2019 and was approved by Cambodian NECHR reference: 007, 10th January 2020, and OxTREC approval reference: 23-19, 15th August 2019. All respondents gave written informed consent prior to participation to the trial.
: The authors declare that they have no competing interests.
